The objective of the Administrative Core is to provide overall guidance, coordination and leadership for the Center. The administrative and scientific leadership of the Center is provided by Dr. N.F. LaRusso, Director, and Drs. G. Farrugia, G.J Gores, and V.H. Shah, Associate Directors, in conjunction with an Executive Committee, an Internal Advisory Committee-, and an External Advisory Committee. The Executive Committee is comprised of the Director, Associate Directors, Core Directors, and the Leaders of the Mechanistic Research Theme groups (Signal Transduction, Membrane Receptors/Ion Channels, and Genetics/Gene Regulation) and meets monthly. The Executive Committee will periodically assess the Research Base striving to enhance membership by committed investigators, especially by attracting additional investigators to pursue digestive disease studies. The Internal Advisory Committee will meet quarterly and will provide regular input to the Executive Committee regarding the strategic direction of the Center and will facilitate communication with institutional leaders to ensure that the Center remains responsive to overall institutional needs. The External Advisory Committee consists of four internationally prominent investigators who are leaders in digestive disease research and will meet annually in person and by conference call as needed to provide regular feedback to the Executive Committee. An Administrator will provide the necessary support for real-time financial management and operations of the Center. The administrative leadership will assure responsiveness of the Center Cores to the needs of the Research Base, and provide oversight for Core functions. In addition, the Administrative Core will support and manage the Scientific Enrichment Program, which is comprised of: i.) a seminar series involving intra- and extra-mural speakers;ii.) research retreats for the Center members and fellows/graduate students;and, iii.) a Mini-Sabbatical Program. Finally, the Administrative Core will coordinate the Pilot and Feasibility Program, which is designed to attract new and seasoned investigators to pursue digestive disease research. This Administrative Core is already functional as illustrated by the coordinated efforts required to develop and submit this proposal.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK084567-03
Application #
8309300
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
3
Fiscal Year
2011
Total Cost
$412,791
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Mansini, Adrian P; Lorenzo Pisarello, Maria J; Thelen, Kristen M et al. (2018) MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma. Hepatology 68:561-573
Moncsek, Anja; Al-Suraih, Mohammed S; Trussoni, Christy E et al. (2018) Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice. Hepatology 67:247-259
Allen, Alina M; Shah, Vijay H; Therneau, Terry M et al. (2018) The role of 3D-MRE in the diagnosis of NASH in obese patients undergoing bariatric surgery. Hepatology :
Dhanasekaran, Renumathy; Nault, Jean-Charles; Roberts, Lewis R et al. (2018) Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy. Gastroenterology :
Sugihara, Takaaki; Werneburg, Nathan W; Hernandez, Matthew C et al. (2018) YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity. Mol Cancer Res 16:1556-1567
Rizvi, Sumera; Fischbach, Samantha R; Bronk, Steven F et al. (2018) YAP-associated chromosomal instability and cholangiocarcinoma in mice. Oncotarget 9:5892-5905
Anderson, Bradley W; Suh, Yun-Suhk; Choi, Boram et al. (2018) Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma. Clin Cancer Res 24:5724-5734
Rizvi, Sumera; Khan, Shahid A; Hallemeier, Christopher L et al. (2018) Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15:95-111
Mouchli, Mohamad A; Ouk, Lidia; Scheitel, Marianne R et al. (2018) Colonoscopy surveillance for high risk polyps does not always prevent colorectal cancer. World J Gastroenterol 24:905-916
Allen, Alina M; Therneau, Terry M; Larson, Joseph J et al. (2018) Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study. Hepatology 67:1726-1736

Showing the most recent 10 out of 537 publications